|
2023/11/21
|
Applied Stem Cell Biology, Dr. Linn Streubel-Gallasch
|
The retromer and seeding assay projects - Update
|
-
|
-
|
|
2023/11/28
|
Integrative Omics in Parkinson Disease, Carolin Gabbert
|
Identifying the genetic cause in Norwegian families with Parkinson’s disease
|
Integrative Omics in Parkinson Disease, Theresa Lüth
|
A blood-based marker of mitochondrial DNA damage in Parkinson’s disease, 10.1126/scitranslmed.abo1557
|
|
2023/12/07
|
-
|
-
|
Genetics of Rare Diseases, Kaja Schröder
|
De novo retinoic acid receptor beta (RARB) variant associated with microphthalmia and dystonia, 10.1016/j.ejmg.2023.104802
|
|
2024/01/09
|
Integrative Omics in Parkinson Disease, Dr. Joanne Trinh
|
Overview of present and future projects in the Integrative Omics research group
|
-
|
-
|
|
2024/01/16
|
Genetics of Rare Diseases, Aida Diaw
|
Tissue-specific imprinting of SGCE and expressional changes in dystonia
|
-
|
-
|
|
2024/01/23
|
-
|
-
|
Applied Stem Cell Biology, Dr. Linn Streubel-Gallasch
|
Propagative α-synuclein seeds as serum biomarkers for synucleinopathy, 10.1038/s41591-023-02358-9
|
|
2024/02/06
|
Molecular Mechanisms of Movement Disorders, Arian Hach
|
Progress on PRKN Exon 2 deletion project
|
-
|
-
|
|
2024/02/20
|
Translational Neurogenetics, Dr. Christine Klein
|
Neurogenetics in the Clinic
|
-
|
-
|
|
2024/03/05
|
Applied Stem Cell Biology, Hannah Wimmerstedt
|
Differentiation and Characterization of Astrocytes
|
-
|
-
|
|
2024/03/12
|
Genetics of Rare Diseases, Dr. Katja Lohmann
|
Updates from the group - Molecular Genetics of Rare Diseases
|
Integrative Omics in Parkinson Disease, Dr. Joanne Trinh
|
A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase, 10.1101/2024.01.17.24300927
|
|
2024/04/02
|
Integrative Omics in Parkinson Disease, Carolin Gabbert
|
The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease
|
Translational Neurogenetics, Dr. Maria Leila Doquenia
|
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease, 10.1038/s41588-023-01584-8
|
|
2024/04/09
|
Molecular Mechanisms of Movement Disorders, Arian Hach
|
Remaining Parkin function & later AAO in homozygous PRKNdelEx2 carriers
|
-
|
-
|
|
2024/04/16
|
Translational Neurogenetics, Dr. Cholpon Shambetova
|
Report from Kyrgyzstan: Training and Progress in Building a New Cohort
|
Molecular Mechanisms of Movement Disorders, Dr. Aleksandar Rakovic
|
A mutational atlas for Parkin proteostasis, 10.1038/s41467-024-45829-4
|
|
2024/04/23
|
Applied Stem Cell Biology, Letizia Santinelli
|
Investigation of the morphological and molecular effect of the phosphatase PTEN in primary murine Schwann cells
|
Genetics of Rare Diseases, Dr. Katja Lohmann
|
Dissecting genetic architecture of rare dystonia: genetic, molecular and clinical insights, 10.1136/jmg-2022-109099
|
|
2024/04/30
|
Integrative Omics in Parkinson Disease, Joshua Laß
|
Mid-point seminar for PhD thesis
|
Applied Stem Cell Biology, Dr. Linn Streubel-Gallasch
|
MDS-ES FOCUSED WORKSHOP: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism
|
|
2024/05/07
|
Genetics of Rare Diseases, Pin-Jui Kung
|
Elevated TAOK1 Levels in Plasma-Derived Extracellular Vesicles: A Diagnostic Marker for Cognitive Decline in Parkinson’s Disease Dementia and Alzheimer’s Disease
|
-
|
-
|
|
2024/05/30
|
Functional Genetics of Movement Disorders, Dr. Ana Westenberger
|
Rostock International Parkinson's Disease Study (ROPAD)
|
-
|
-
|
|
2024/06/06
|
Translational Neurogenetics, Dr. Christine Klein
|
New biological classifications of Parkinson's disease
|
-
|
-
|
|
2024/06/13
|
Molecular Mechanisms of Movement Disorders, Kerstin Tanzer
|
Progress Report on the DYT-TOR1A Project
|
Translational Neurogenetics, Dr. Karen Grütz
|
Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing, 10.1016/j.nbd.2023.106367
|
|
2024/06/25
|
Applied Stem Cell Biology, Dr. Linn Streubel-Gallasch
|
Update: seed amplification assay and extracellular vesicle isolation
|
-
|
-
|
|
2024/07/04
|
-
|
-
|
Genetics of Rare Diseases, Lena Nothacker
|
eIF2α phosphorylation evokes dystonia-like movements with D2-receptor and cholinergic origin and abnormal neuronal connectivity, 10.1101/2024.05.14.594240
|
|
2024/07/18
|
Integrative Omics in Parkinson Disease, André Fienemann
|
Optical genome mapping and long-read sequencing of structural variants in Parkinson’s disease-related induced pluripotent stem cells
|
-
|
-
|
|
2024/07/23
|
Applied Stem Cell Biology, Dr. Philip Seibler
|
Annual lab safety instructions
|
Molecular Mechanisms of Movement Disorders, Arian Hach
|
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset, 10.1038/s41467-024-48961-3
|
|
2024/08/27
|
Genetics of Rare Diseases, Dr. Katja Lohmann
|
Update of research section projects
|
-
|
-
|
|
2024/09/23
|
Integrative Omics in Parkinson Disease, Carolin Gabbert
|
Gene-environment modifiers in Parkinson’s disease
|
-
|
-
|
|
2024/10/10
|
Translational Neurogenetics, Dr. Christine Klein
|
Antisense oligonucleotides enhance SLC20A2 expression and suppress brain calcification in a humanized mouse model
|
Translational Neurogenetics, Alexander Balck
|
Antisense oligonucleotides enhance SLC20A2 expression and suppress brain calcification in a humanized mouse model" (doi: 10.1016/j.neuron.2024.07.013)
|
|
2024/10/14
|
Translational Neurogenetics, Dr. Christine Klein
|
Biallelic NAA60 variants with impaired N-terminal acetylation capacity cause autosomal recessive primary familial brain calci cations".
|
Translational Neurogenetics, Max Brand
|
Biallelic NAA60 variants with impaired N-terminal acetylation capacity cause autosomal recessive primary familial brain calci cations" (doi: 10.1038/s41467-024-46354-0).
|
|
2024/10/10
|
Applied Stem Cell Biology, Dr. Philip Seibler
|
Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs".
|
Applied Stem Cell Biology, Letizia Santinelli
|
Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs" (doi: 10.1126/sciadv.adk3700).
|
|
2024/11/19
|
Translational Neurogenetics, Dr. Christine Klein
|
The role of dopaminergic medication and specific pathway alterations in idiopathic and PRKN/PINK1-mediated Parkinson's diseache.
|
Translational Neurogenetics, Alexander Balck
|
-
|
|
2024/11/28
|
Integrative Omics in Parkinson Disease, Dr. Joanne Trinh
|
Single Cell RNA Sequencing of frozen human post-mortem brain.
|
Integrative Omics in Parkinson Disease, Joshua Laß
|
-
|
|
2024/12/03
|
-
|
Role of the immune system in dystonia
|
-
|
-
|
|
2024/12/03
|
Translational Neurogenetics, Dr. Christine Klein
|
First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification.
|
Translational Neurogenetics, Alexander Balck
|
-
|
|
2025/01/09
|
Genetics of Rare Diseases, Dr. Katja Lohmann
|
First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification.
|
Genetics of Rare Diseases, Linn Welzel
|
-
|
|
2025/01/09
|
Genetics of Rare Diseases, Dr. Katja Lohmann
|
First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification.
|
Genetics of Rare Diseases, Linn Welzel
|
-
|
|
2025/01/23
|
Integrative Omics in Parkinson Disease, Dr. Joanne Trinh
|
Genomic analysis of early-onset Parkinson's disease using long-read sequencing and optical genome mapping.
|
Integrative Omics in Parkinson Disease, André Fienemann
|
-
|
|
2025/01/28
|
Translational Neurogenetics, Dr. Christine Klein
|
PD prevalence study in Kyrgyzstan: a village-based pilot.
|
Translational Neurogenetics, Cholpon Shambetova
|
-
|
